Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Blokhin's Russian Cancer Research Center
Hoffmann-La Roche
UMC Utrecht
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Neonc Technologies, Inc.
Jonsson Comprehensive Cancer Center
Iambic Therapeutics, Inc
Barbara Ann Karmanos Cancer Institute
Adela, Inc
Mayo Clinic
University of Southern California
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
AVM Biotechnology Inc
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Poitiers University Hospital
National Cancer Institute (NCI)
Apollomics Inc.
NRG Oncology
Mayo Clinic
Columbia University
Tempus AI